 |
|
New compound 'highly efficacious' at reducing human tumour growth
July 06, 2004Innsbruck, Austria: Treatment with a new dual cell cycle and angiogenesis pathway inhibitor blocks VEGF-induced vascular permeability, inhibits tumour angiogenesis and induces apoptosis in human tumour models said Dr Gerhard Siemeister of Schering AG, Corporate Research, Berlin speaking at the 18th meeting of the European Association of Cancer Research today (Tuesday 6 July, 2004).
Loss of cell cycle control (runaway growth) and tumour-induced angiogenesis (development of new blood vessels to supply the growing tumour with oxygen) are two major hallmarks of cancer. Loss of cell cycle control as a consequence of aberrant cyclin-dependent kinase (CDK) control has been directly linked to the molecular pathology of cancer. CDK's are a family of enzymes required for the correct timing and order of events in the cell division cycle. Vascular endothelial growth factor (VEGF) / VEGF-receptor tyrosine kinase (VEGF-RTK) and platelet-derived growth factor (PDGF)-RTKs are two molecules known to be involved in tumour angiogenesis.
The new compound, called 'ZK-CDK', is a novel, chemically synthesized small molecule ATP-competitive kinase inhibitor that is unique in that combines the inhibition of tumour cell growth as well as inhibition of tumour angiogenesis in one single molecule.
ZK-CDK was shown to inhibit a range of CDK's as well as VEGF-RTK's and PDGF-RTK's resulting in an inhibition of the proliferation of human tumour cell lines in vivo. ZK-CDK blocked cell cycle progression in G1 and induced apoptosis, blocked VEGF-induced vascular permeability in vivo and reduced the blood supply of human tumour xenografts. "These animal data are very promising in terms of anti-tumour efficacy and tolerability", said Dr Siemeister. "VEGF-RTK inhibitors have been shown to be well-tolerated by patients and we hope that ZK-CDK will be well tolerated. The CDK inhibiting mechanism of ZK-CDK, in contrast to cytotoxic chemotherapy, should arrest the proliferation of normal cells but not kill them, allowing them to recover during drug-free cycles".
ZK-CDK was tested on mice as an oral preparation. The compound was tested against several tumour models including both solid tumours and haematological tumours. The compound showed efficacy in all models. However, ZK-CDK was particularly efficacious in slow-growing, hormone-independent, p53-negative models e.g. advanced, anti-hormone refractory breast and prostate tumours.
"This new compound is highly efficacious at inhibiting tumour growth and works by acting on two separate mechanisms that are involved in the development and perpetuation of human cancer cells", said Dr Siemeister. The compound has already entered phase I clinical trials to determine tolerability and pharmacokinetics in humans and to establish its efficacy in humans".
Federation of European Cancer Societies (FECS)
Cancer News and Current Cancer Events RSSBisphenol A linked to metabolic syndrome in human tissue
New research from the University of Cincinnati (UC) implicates the primary chemical used to produce hard plastics-bisphenol A (BPA)-as a risk factor for metabolic syndrome and its consequences.
African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD).
Atomic structure of the mammalian 'fatty acid factory' determined
Mammalian fatty acid synthase is one of the most complex molecular synthetic machines in human cells. It is also a promising target for the development of anti-cancer and anti-obesity drugs and the treatment of metabolic disorders.
International team reveals first prognosticator of survival in aggressive cancer
The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma (STS).
M. D. Anderson study finds change in HER2 status after treatment with Herceptin
Researchers at The University of Texas M. D. Anderson Cancer Center have discovered that when treated with Herceptin prior to surgery, 50 percent of HER2 positive, breast cancer patients showed no signs of disease at the time of surgery.
M. D. Anderson study finds racial disparities in radiation therapy rates for breast cancer
Black women are less likely than white women to receive radiation therapy after a lumpectomy, the standard of care for early stage breast cancer, according to a new study by researchers at The University of Texas M. D. Anderson Cancer Center.
NC State Is First University in Nation to Offer Canine Bone Marrow Transplants
Dogs suffering from lymphoma will be able to receive the same type of medical treatment as their human counterparts, as North Carolina State University becomes the first university in the nation to offer canine bone marrow transplants in a clinical setting.
DNA editing tool flips its target
Imagine having to copy an entire book by hand without missing a comma. Our cells face a similar task every time they divide. They must duplicate both their DNA and a subtle pattern of punctuation-like modifications on the DNA known as methylation.
What a Sleep Study Can Reveal About Fibromyalgia
Research engineers and sleep medicine specialists from two Michigan universities have joined technical and clinical hands to put innovative quantitative analysis, signal-processing technology and computer algorithms to work in the sleep lab.
Stem cell research puts interstate rivalry on hold
Victoria and New South Wales have put aside their competitive interstate rivalry to collaborate on a stem cell research project, as announced by Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research, Verity Firth, today.
More Cancer News Articles
 | The Last Lecture by Randy Pausch, Jeffrey Zaslow "We cannot change the cards we are dealt, just how we play the hand." --Randy Pausch A lot of professors give talks titled "The Last Lecture." Professors are asked to consider their demise and to ruminate on what matters most to them. And while they speak, audiences can't help but mull the same question: What wisdom would we impart to the world if we knew it was our last chance? If we had to... |
 | My Sister's Keeper: A Novel by Jodi Picoult New York Times bestselling author Jodi Picoult is widely acclaimed for her keen insights into the hearts and minds of real people. Now she tells the emotionally riveting story of a family torn apart by conflicting needs and a passionate love that triumphs over human weakness.Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots... |
 | The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health by T. Colin Campbell, Thomas M. Campbell II Referred to as the "Grand Prix of epidemiology" by The New York Times, this study examines more than 350 variables of health and nutrition with surveys from 6,500 adults in more than 2,500 counties across China and Taiwan, and conclusively demonstrates the link between nutrition and heart disease, diabetes, and cancer. While revealing that proper nutrition can have a dramatic effect on reducing... |
 | Eat to Live: The Revolutionary Formula for Fast and Sustained Weight Loss by Joel Fuhrman When Mehmet Oz or any of New York's leading doctors has a patient whose life depends on losing weight, they call on Joel Fuhrman, M.D. In EAT TO LIVE, Dr. Fuhrman offers his healthy, effective, and scientifically proven plan for shedding radical amounts of weight quickly, and keeping it off.Losing weight under Dr. Fuhrman's plan is not about willpower, it is about knowledge. The key to this... |
 | Silent Spring by Rachel Carson Silent Spring, released in 1962, offered the first shattering look at widespread ecological degradation and touched off an environmental awareness that still exists. Rachel Carson's book focused on the poisons from insecticides, weed killers, and other common products as well as the use of sprays in agriculture, a practice that led to dangerous chemicals to the food source. Carson argued that... |
 | It's Not About the Bike: My Journey Back to Life by Lance Armstrong, Sally Jenkins People around the world have found inspiration in the story of Lance Armstrong--a world-class athlete nearly struck down by cancer, only to recover and win the Tour de France, the multiday bicycle race famous for its grueling intensity. Armstrong is a thoroughgoing Texan jock, and the changes brought to his life by his illness are startling and powerful, but he's just not interested in wearing a... |
 | Anticancer: A New Way of Life by David Servan-Schreiber A radical synthesis of science and personal experience that advocates a sea change in the way we understand and confront cancerWhen David Servan- Schreiber, a dedicated scientist and doctor, was diagnosed with brain cancer, it changed his life. Confronting what medicine knows about the illness, the little known workings of the body’s natural cancer-fighting capacities, and his own will to live,... |
 | Good Calories, Bad Calories by Gary Taubes In this groundbreaking book, the result of seven years of research in every science connected with the impact of nutrition on health, award-winning science writer Gary Taubes shows us that almost everything we believe about the nature of a healthy diet is wrong.For decades we have been taught that fat is bad for us, carbohydrates better, and that the key to a healthy weight is eating less and... |
 | Autobiography of a Face by Lucy Grealy At age nine, Lucy Grealy was diagnosed with a potentially terminal cancer. When she returned to school with a third of her jaw removed, she faced the cruel taunts of classmates. In this strikingly candid memoir, Grealy tells her story of great suffering and remarkable strength without sentimentality and with considerable wit. Vividly portraying the pain of peer rejection and the guilty... |
 | Beating Cancer with Nutrition by Patrick Quillin Beating Cancer with Nutrition · Sugar feeds Cancer: diet and supplements can starve tumors · Nutrition makes chemo and radiation more toxic to the tumor while protecting the patient · Nutrition changes underlying causes of cancer, improving outcome for cancer patients regardless of other therapies. Why Beating Cancer with Nutrition is unique: The book was developed after working... |
| © 2008 BrightSurf.com |